460
Participants
Start Date
January 31, 2005
Primary Completion Date
November 30, 2006
Study Completion Date
November 30, 2006
Degarelix
Drug: Degarelix subcutaneous 240 mg (40 mg/mL) initiation dose, maintenance dose 240 mg (40 mg/mL) at months 1, 3, 6 and 9
Degarelix
Drug: Degarelix subcutaneous 240 mg (40 mg/mL) initiation dose, maintenance dose 240 mg (60 mg/mL) at months 1, 3, 6 and 9
Degarelix
Drug: Degarelix subcutaneous 240 mg (40 mg/mL) initiation dose, maintenance dose 240 mg (60 mg/mL) at months 1, 4, 7 and 10
State College Urologic Association, State College
The Urology Center, Greensboro
Northeast Urology Research, Concord
Grand Strand Urology, Myrtle Beach
South Florida Medical Research, Aventura
RT Services, Inc, Fort Myers
SW Florida Urological Associates, Fort Myers
Urology Centers of Alabama, Homewood
Medical Affiliationed Research Center, Huntsville
Mississippi Urology Clinic, Jackson
Kansas City Urology Care, Kansas City
University of Missouri, Urology, Deptof Surgery, Columbia
Regional Urology, Shreveport
Urology Association of Northern Texas, Fort Worth
Urology San Antonio Research, San Antonio
Urology Research Option, Aurora
Western Clinical Research, Torrance
West Coast Clinical Research, Tarzana
Center for Urological Research, La Mesa
South Orange County Medical Research Center, Laguna Woods
Advanced Urology Medical Center, Anaheim
Seatle Urology Research Centre, Seattle
Alaska Clinical Research Center, LLC, Anchorage
UZ Gasthuisberg Leuven, Leuven
Southern Interior Medical Research Corp, Kelowna
Andreou Researce, Surrey
Can-Med Clinical Research Inc., Victoria
The Male/Female Health Centres and Research, Barrie
Brantford Urology Research, Brantford
North Bay Hospital, North Bay
The Male/Female Health Centres and Research, Oakville
The Male Health Center, Toronto
Helsinki University Hospital, Maria Hospital, Dept Urology, Helsinki
Central Hospital, North Karelian, Dept. of Urology, Joensuu
Oulu University Hospital, Department of Surgery Division of Urology, Oys
Tampere University Hospital, Dept. of Urology, Tampere
Centre Hospitalier Départemental des Oudairies, Chirurgie Urologie, La Roche-sur-Yon
Fédération d'Urologie et Néphrologie, Nice
Gemeinschaftspraxis Dres Effert und Benedic, Aachen
Klinik fuer Urologie, Vivantes Klinikum Am Urban, Berlin
Academic Medical Center, Urology, Amsterdam
St. Elisabeth Hospital, Tilburg
Centrul Medical Privat, Arad
"Clinical Hospital Prof. Dr. Theodor Burghele, Urology Department", Bucharest
University CF Hospital No.2, Urology Clinic, Bucharest
Andros Clinic, Saint Petersburg
City Hospital #15, Saint Petersburg
City Hospital #26, Saint Petersburg
Pavlov State Medical University, Outpatient Diagnostic Center affiliated with the Urology Department, Saint Petersburg
Pavlov State Medical University, Urology Department, Saint Petersburg
Clinical Center of Serbia Institute of Urology and Nephrology, Belgrade
Clinical Center Novi Sad, Clinic of Urology Hajduk, Novi Sad
Ward 10, NHS Forth Valley Acute Operating Division, Falkirk and District Royal Infirmary, Falkirk
Mount Vernon Cancer Centre, Marie Curie Research Wing, Middlesex
Castle Hill Hospital, Dept. Urology, North Humberside
Level 7, Urology Research Unit, Derriford Hospital, Plymouth
Lead Sponsor
Ferring Pharmaceuticals
INDUSTRY